Novel modalities powering commercial scale-up in advanced therapies

As the field of advanced therapies matures, developers must adapt manufacturing strategies to support diverse and complex modalities. This spotlight session highlights novel approaches that improve scalability, cost control, and production consistency across modalities such as cell, gene, and nucleic acid-based therapies. Attendees will gain practical insight into design considerations for translating novel therapeutic formats into commercially viable processes. 

Key takeaways:

• Examine new modality-specific challenges in commercial scale-up 

• Identify enabling technologies that enhance manufacturing flexibility and efficiency 

• Discuss integration of platform processes to support diverse therapy types 

• Evaluate strategies for reducing cost and variability during large-scale production 

• Review case examples demonstrating successful commercial-scale implementation